Detalhe da pesquisa
1.
Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy.
Breast Cancer Res Treat
; 153(2): 435-43, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26296701
2.
Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results.
J Neurooncol
; 92(2): 165-75, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19066728
3.
Evaluation of lapatinib and topotecan combination therapy: tissue culture, murine xenograft, and phase I clinical trial data.
Clin Cancer Res
; 14(23): 7900-8, 2008 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19047120
4.
A limited sample model to predict area under the drug concentration curve for 17-(allylamino)-17-demethoxygeldanamycin and its active metabolite 17-(amino)-17-demethoxygeldanomycin.
Cancer Chemother Pharmacol
; 61(1): 39-45, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17909811
5.
The Impact of T2/FLAIR Evaluation per RANO Criteria on Response Assessment of Recurrent Glioblastoma Patients Treated with Bevacizumab.
Clin Cancer Res
; 22(3): 575-81, 2016 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26490307
6.
Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51.
Int J Radiat Oncol Biol Phys
; 81(1): 218-24, 2011 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21549518
7.
Detrimental effects of tumor progression on cognitive function of patients with high-grade glioma.
J Clin Oncol
; 24(34): 5427-33, 2006 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17135644